Linues Medical Receives Patent for SafeBreak® Vascular Generation 2

FAYETTEVILLE, Ark. - EntSun -- Lineus Medical, the leader in vascular access innovation, has been awarded a U.S. patent for SafeBreak® Vascular Generation 2, the next evolution of the company's flagship breakaway device. The newly patented design features a single-valve system, replacing the original device's two-valve configuration. The ideas captured in the patent allow the device to have a significantly smaller profile while maintaining the device's core function of protecting IV lines from damaging external forces by separating. The patent also includes the ability to add a light and/or sound notification for nurses when the device separates. The current version of SafeBreak relies on IV pump alarm to alert nurses of a separation. Having an alarm on SafeBreak will help open up the home healthcare and gravity line IV market for the company.

SafeBreak Vascular is the only breakaway device for IV lines clinically proven to reduce multiple IV complications.¹ When a damaging force is placed on the line, SafeBreak intentionally separates to remove the force and protect the patient's IV.   When separation occurs, valves on both ends of the device close to prevent medication leakage from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money.¹

More on EntSun News

• Comp-U-Floor Unveils Powerful New Commercial Module
• Hollywood Plays It Safe. Mud and Silk Doesn't — Meet the Heroine the Elites Are Afraid Of
• Revenue Optics Announces the Appointment of Sonal Chowdhury as Senior Manager – Strategic Operations
• How California Convinces Buyers Not to Purchase New Cars — and How This Hurts Dealers
• Higgland Studios Introduces New Artist Higginswerx

"Lineus Medical continues to innovate and be the thought leader both clinically and scientifically in the breakaway device market.", said Vance Clement, CEO of Lineus Medical. "SafeBreak Gen 2 will move us closer to accomplishing our mission of removing the pains associated with IV lines for patients, nurses, and hospitals."

"The SafeBreak Gen 2 design reflects our ongoing commitment to the continuous improvement of SafeBreak," said Will Armstrong, COO of Lineus Medical. "This patent showcases how our engineering team is advancing breakaway device technology with smarter, simpler design solutions that improve patient care while further strengthening the company's intellectual property portfolio."

About Lineus Medical

Lineus Medical is the developer of SafeBreak® Vascular, a breakaway technology proven to reduce IV restarts and IV complications.¹ More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.

References:

1. Data on file.